Syncope, a transient loss of consciousness due to global cerebral hypoperfusion, presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnosing and managing syncope in clinical practice.
It is crucial to classify syncope into reflex, orthostatic hypotension, and cardiac syncope. Reflex syncope, the most common, includes vasovagal, situational, and carotid sinus syncope. Orthostatic hypotension could be due to autonomic failure, volume depletion or drug-induced. Cardiac syncope, the most life-threatening, can be due to arrhythmias or structural heart diseases.
A structured approach to diagnosis involves a detailed history, physical examination, and targeted investigations. The history should focus on identifying prodromal symptoms, triggers, and family history of sudden cardiac death. The physical examination should include orthostatic blood pressure measurements and cardiovascular examination. Electrocardiogram (ECG) is the most important initial investigation. Further investigations like echocardiography, tilt table testing, Holter monitoring, or electrophysiological studies may be required based on initial findings.
Management should be directed towards the underlying cause. Reflex syncope can often be managed with lifestyle modifications and patient education. Orthostatic hypotension requires volume replacement, discontinuation of offending drugs, and sometimes pharmacotherapy. Cardiac syncope may require antiarrhythmic drugs, pacemakers, or even defibrillators.
Despite the diagnostic challenge, a systematic approach can aid in identifying the underlying cause of syncope. Timely diagnosis and appropriate management can significantly reduce morbidity and mortality associated with this condition. Continued research is needed to further our understanding of this complex clinical entity and to develop more effective diagnostic and therapeutic strategies.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation